The first is glucagon-like peptide-1, otherwise known as GLP-1
Post-treatment weight regain following discontinuation of GLP-1 receptor agonist therapy
36 Generally, drugs with smaller molecular weights are considered to have more potential in this regard
"That's why preserving muscle is so important, especially during weight-loss treatments - it's not just about staying strong, but about keeping our whole body resilient and healthy." In the commentary, the authors suggest that muscle loss due to weight reduction may also exacerbate conditions like sarcopenic obesity - characterised by a combination of high body fat and low skeletal muscle mass - which contributes to poorer health outcomes, including cardiovascular disease and higher mortality rates
While its weight loss efficacy may be less pronounced compared to GLP-1, Ozempic, and Wegovy, Trulicity still offers meaningful benefits in terms of weight reduction and glycemic control
After a series of clinical trials and case studies, the results were extremely positive
